T1	Participants 71 100	patients with advanced cancer
T2	Participants 582 697	Patients with advanced cancer with a fatigue score of â‰¥ 4 out of 10 on the Edmonton Symptom Assessment Scale (ESAS)
T3	Participants 1050 1095	One hundred forty-one patients were evaluable
